In the sensitivity analyses with grace periods of 30 and 90 days, female patients receiving their first CSA prescription by a rheumatologist were also at a reduced risk of CSA discontinuation ( Supplementary eTable S8 and Supplementary eTable S9 ), while the result was borderline non-significant in the main analysis (HR = 0.75, 95% CI: 0.55–1.01).
← all excerpts
Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada.
1
—
—